Sunday, 08 December 2019

New Zealand News

  • NZ firm's multiple sclerosis drug gets US patent

    New Zealand |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 18 Dec, 2012

    Singapore: A new drug for the treatment of secondary progressive multiple sclerosis (SPMS) called MIS416, developed by New Zealand biopharmaceutical company Innate Immunotherapeutics, has ...Read more

  • Digital healthcare, the next big thing

    New Zealand |  Opinion | By Nandita Singh | 0 Comment | 07 Aug, 2013

    A radical shift in how healthcare is delivered globally is underway. Game-changing developments in sensor technologies with applications in diagnostics, big data and mobile healthcare apps ...Read more

  • BS Survey: Healthcare is getting smarter in Asia

    New Zealand |  Analysis | By BioSpectrum Bureau  | 0 Comment | 30 Nov, 2012

    ...Read more

  • Aussies to get breast cancer treatment analysis

    New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 07 Jan, 2014

    Singapore: Australian women will potentially have greater access to the only genomic test validated to predict whether patients with early-stage invasive breast cancer would benefit from ch...Read more

  • BSA-CMR Survey: APAC CROs stick to an average of 50 clients

    New Zealand |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2013

    The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

  • What services do APAC CROs offer to their clients?

    New Zealand |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2013

    The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

  • New Zealand university gets $1 mn for diabetes research

    New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 20 Sep, 2012

    Singapore: The University of Canterbury scientists in New Zealand are seeking a major medical breakthrough in potentially identifying people most at risk of becoming diabetic. The universit...Read more

  • Genetically altered cow's milk to address allergies

    New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 04 Oct, 2012

    Singapore: Scientists at AgResearch in Hamilton, New Zealand, have bred the first cow in the world to produce high protein milk that may be hypo-allergenic. The cow's milk can exclusively a...Read more

  • Nylon producer Invista to collaborate with LanzaTech

    New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 13 Aug, 2012

    Singapore: World-leading nylon producer Invista and biotechnology firm LanzaTech have signed a joint development agreement focused on bio-based butadiene. According to the agreement, Invist...Read more

  • Celgene halts phase III trial of cancer drug Revlimid

    New Zealand |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 19 Jul, 2013

    Singapore: Celgene has discontinued treatment with Revlimid (lenalidomide), prescribed for for multiple myeloma, in open-label, phase III ORIGIN trial, which enrolled 450 patients in over 1...Read more

  • Connected care' is the new mantra of APAC healthcare

    New Zealand |  Opinion | By BioSpectrum Bureau  | 0 Comment | 29 Aug, 2013

    Health systems around the Asia-Pacific region and beyond are under pressure from the increasing demands of an aging population and rising rates of chronic illness. Many are responding wit...Read more

  • NZ, Aus govt commit $2.5 mn for rheumatic vaccine

    New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 22 Feb, 2013

    Singapore: The decision by New Zealand and Australian Prime Ministers to investigate potential vaccines against rheumatic fever has been welcomed by the University of Auckland, New Zealand....Read more

  • Mylan to develop, market Biocon generic insulin

    New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 14 Feb, 2013

    Bangalore: India's No 2 biotech company, Bangalore-based Biocon has announced a strategic partnership with global generics major, Mylan, based in Pittsburgh, US, to sell its three insulin a...Read more

  • Transplant pig cells into human brain to treat Parkinson's

    New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 19 Nov, 2012

    Singapore: Living Cell Technologies (LCT) has received ethical approval from the New Zealand Ministry of Health's Health and Disability Ethics Committee to proceed with phase I clinical tr...Read more

  • BioSpectrum Asia launches 5th CRO survey

    New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jul, 2013

    Singapore: After four consecutive successful annual surveys on the developments in the clinical research industry, BioSpectrum Asia has now launched the fifth annual survey of the contract ...Read more

  • Largest NZ drug maker to remain a family business

    New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 30 Nov, 2012

    Singapore: Douglas Pharmaceuticals, New Zealand's largest pharmaceutical manufacturer, will continue to remain a family owned business. The company had received a number of purchase offer...Read more

  • Nottingham university gets $25 mn for synthetic biology research

    New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 15 Nov, 2012

    Singapore: The University of Nottingham has been awarded funding of $4.5 million (£2.9 million) to help make low-carbon fuel. In a move that could potentially revolutionize major UK indu...Read more

  • LCT conducts first implant of regenerative therapy

    New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 20 Sep, 2013

    Singapore: Australia-based Living Cell Technologies (LCT) has implanted regenerative cell therapy NTCELL, a treatment for Parkinson's disease in the first patient in phase I clinical trial....Read more



Podcast

 

Survey Box

Is APAC region emerging as a leader in assistive technologies?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls